| Financial Year |
March 31 2023 |
| Monetary Funds |
1,681,330,677.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
32,812,386.59 |
| Accounts Receivable |
173,746,372.15 |
| Advances to Suppliers |
43,587,668.80 |
| Other Receivables |
11,767,848.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
589,182,900.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,712,976.68 |
| Total Current Assets |
2,573,140,830.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,594,920.65 |
| Investment Properties |
47,654,589.74 |
| Fixed Assetes |
145,759,397.47 |
| Under-construction Projects |
7,829,392.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,247,406.11 |
| R&D expenses |
-- |
| Goodwill |
1,076,163.60 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
35,828,320.66 |
| Other Non-Current Assets |
4,910,251.50 |
| Sub-Total of Non-Current Assets |
279,836,782.37 |
| Total Assets |
2,852,977,612.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
251,097,965.69 |
| Accounts Payable |
275,354,548.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
104,794,957.71 |
| Taxes Payable |
10,919,563.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
114,039,639.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
306,556.55 |
| Other Current Liabilities |
51,767,067.90 |
| Sub-Total of Current Liabilities |
1,210,235,691.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
627,736.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,361,322.26 |
| Total Liabilities |
1,276,597,013.73 |
| Paid-In Capital(Or Share Stock) |
446,486,084.00 |
| Capital Surplus |
507,971,730.45 |
| Surplus Reserve |
105,703,713.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
496,823,126.38 |
| Minority Stockholder's Interest |
21,979,113.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,554,401,485.43 |
| Owner's Equity（Stockholder's Equity） |
1,576,380,599.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,852,977,612.94 |
